Pierre Sujobert
Pierre Sujobert is an expert in Hematology at Hospices Civils de Lyon (France). Pierre Sujobert has authored 185 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 729 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Oncology - Neurology - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 185
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Therapeutic success and epidemiological failure in hematology. PMID 42553459 — hematology, therapeutics | Hemasphere | 2026 | 0 |
| Development and External Validation of a Transcriptome-Based Multivariable Prediction Model for Treatment-Free Remission in Chronic Myeloid Leukemia. PMID 42454992 — cells, transcriptome, leukemia, machine learning, leukemia, myeloid, therapeutics, medical oncology, learning, leukemia, myelogenous, chronic, bcr-abl positive | J Clin Oncol Top journal | 2026 | 0 |
| Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study. PMID 42242261 — research design, bone marrow, blood, fibrosis, neoplasms, biopsy, machine learning, diagnosis, learning, artificial intelligence, primary myelofibrosis, hematologic diseases | Lancet Haematol | 2026 | 0 |
| Molecular sleuthing: unmasking hidden lymphomas through plasma DNA sequencing. PMID 41916725 — cells, molecular biology, lymphoma, lymphoma, large b-cell, diffuse, dna, plasma | J Med Genet | 2026 | 0 |
| Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX. PMID 40373272 — hematology, safety, retrospective studies, azacitidine, therapeutics, cytopenia | Blood | 2025 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map